Live
- Online Dating and AI: It's a New Age Love Story, says GenZ Daters
- Trees take on myriad unique forms in Ompal Sansanwal's solo exhibition
- Party gives everyone opportunities: Punjab Congress chief at Faridkot campaign
- Nikhil, Dhruva & Nikeetaa secure titles in INAC 2024
- Swati Sharma completed 60 parikramas around Shivling to get scene right
- 189 plaints of MCC violations, 23 cases against hate speeches lodged in Karnataka
- Afridi, Chapman rise; Suryakumar remains No.1 T20 batter in latest ICC T20I rankings
- RBI issues red alert on illegal entities in forex market
- Defence Minister Rajnath Singh slams Congress over 'appeasement' politics
- WB moves SC against Calcutta HC order axing 25,753 school jobs
Dr Reddy’s announces sale of Cloderm to EPI Health
Highlights
Dr Reddys Laboratories DRL on Tuesday said its whollyowned subsidiary Promius Pharma has sold rights of cloderm cream and its authorised generic to EPI Health, LLC
Hyderabad: Dr Reddy's Laboratories (DRL) on Tuesday said its wholly-owned subsidiary Promius Pharma has sold rights of cloderm cream and its authorised generic to EPI Health, LLC.
"Promius Pharma, LLC, has sold its rights of Cloderm (clocortolone pivalate) cream, 0.1 per cent and its authorised generic to EPI Health, LLC, an affiliate of EPI Group, LLC," DRL said in a statement.
Ron Owens, President of EPI Health, said: "The addition of this product to our growing portfolio will support our ongoing efforts to build a successful prescription branded franchise in the US while contributing to EPI Health's goal of becoming a leader in medical dermatology."
Next Story
ADVERTISEMENT
